4//SEC Filing
Singh Shawn 4
Accession 0001415889-22-008814
CIK 0001411685other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 3:56 PM ET
Size
5.9 KB
Accession
0001415889-22-008814
Insider Transaction Report
Form 4
Singh Shawn
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Purchase
Common Stock
2022-08-17$0.17/sh+600,000$103,200→ 626,234 total(indirect: By Trust)
Holdings
- 153,998
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.1600 to $0.1975, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Documents
Issuer
VistaGen Therapeutics, Inc.
CIK 0001411685
Entity typeother
Related Parties
1- filerCIK 0001412071
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 3:56 PM ET
- Size
- 5.9 KB